Global Pharmaceutical Logistics Market Forecast and Key Industry Developments Through 2035

According to Market Research Future®, the pharmaceutical logistics market is projected to grow from USD 600.07 Billion in 2025 to USD 1,059.54 Billion by 2035, registering a CAGR of 5.85% from 2026 to 2035. Market growth is assessed across service type, mode of operation, product type and region, with cold-chain logistics and cell & gene therapies among the identified faster-growing segments.

Get Sample Report PDF | https://www.marketresearchfuture.com/sample_request/11540

Quick Facts

Market Size (2025): USD 600.07 Billion

Projected Market Size (2035): USD 1,059.54 Billion

CAGR (2026–2035): 5.85%

Base Year: 2025

Historical Data: 2021–2024

Forecast Period: 2026–2035

Study Period: 2021–2035

Valuation Currency: USD Billion

Market Scope: Global Pharmaceutical Logistics Market by service type, mode of operation, product type and region

Fastest Growing Segments: Value-added Services and Others (4.73% CAGR); Cold-Chain Logistics (5.96% CAGR); Cell & Gene Therapies (6.55% CAGR); Asia-Pacific (5.37% CAGR)

Regions Covered: North America, Europe, APAC, South America, MEA

Key Companies: DHL Group, UPS Healthcare, FedEx Corporation, Kuehne+Nagel, DSV, CEVA Logistics, Cencora, Cryoport Systems, Lineage, Americold Realty Trust, Nichirei Logistics Group, Controlant, TraceLink

What Is the Pharmaceutical Logistics Market?

The pharmaceutical logistics market covers logistics services involved in the transportation, storage, handling and distribution of pharmaceutical products across supply chains. These services support the movement of pharmaceutical goods through logistics networks operating across different modes of operation and service categories.

The market is assessed by service type, mode of operation, product type and region. Pharmaceutical logistics also includes specialized services associated with temperature-sensitive products, with cold-chain logistics and cell & gene therapies identified among the faster-growing segments in the market outlook.

How Big Is the Pharmaceutical Logistics Market?

The pharmaceutical logistics market was valued at USD 600.07 Billion in 2025 and is projected to reach USD 1,059.54 Billion by 2035, registering a CAGR of 5.85% from 2026 to 2035.

The forecast covers the global pharmaceutical logistics market across service type, mode of operation, product type and region. Cold-chain logistics is expected to register a CAGR of 5.96%, while cell & gene therapies are identified with a CAGR of 6.55%. Asia-Pacific is also identified as a faster-growing region, with a CAGR of 5.37%.

What Are the Key Takeaways From the Pharmaceutical Logistics Market?

The market is projected to reach USD 1,059.54 Billion by 2035.

The expected CAGR is 5.85% from 2026 to 2035.

The 2025 market size is USD 600.07 Billion.

Cold-chain logistics is expected to grow at a CAGR of 5.96%.

Cell & gene therapies are identified with a CAGR of 6.55%.

Asia-Pacific is identified with a CAGR of 5.37%.

The market scope includes service type, mode of operation, product type and region.

To learn more about this report — https://www.marketresearchfuture.com/reports/pharmaceutical-logistics-market-11540

What Are the Key Drivers of the Pharmaceutical Logistics Market?

Growth in Specialized Pharmaceutical Logistics Requirements

The pharmaceutical logistics market is assessed across different service types, operating modes and product categories. These dimensions reflect the range of logistics requirements involved in pharmaceutical supply chains, including the handling and distribution of products with specific transportation and storage needs.

Cold-Chain Logistics

Cold-chain logistics is one of the identified faster-growing segments, with a projected CAGR of 5.96%. Its growth outlook reflects the importance of temperature-controlled logistics within pharmaceutical distribution and supply-chain management.

Cell & Gene Therapies

Cell & gene therapies represent another faster-growing segment in the market outlook, with a CAGR of 6.55%. The segment highlights the expanding relevance of logistics services designed to support specialized pharmaceutical product categories.

What Are the Major Trends in the Pharmaceutical Logistics Market?

Cold-Chain Logistics Expansion

Cold-chain logistics is identified as a faster-growing segment, registering a projected CAGR of 5.96%. Temperature-controlled logistics remains a specialized component of pharmaceutical supply chains, particularly for products that require specific storage and transportation conditions.

Logistics for Cell & Gene Therapies

Cell & gene therapies are identified as a faster-growing product category, with a CAGR of 6.55%. The segment's forecast highlights the growing relevance of logistics capabilities tailored to specialized pharmaceutical products.

Growth in Value-added Services and Others

Value-added Services and Others are identified with a CAGR of 4.73%. This segment forms part of the market's growth assessment across pharmaceutical logistics service categories.

What Are the Major Market Opportunities?

Cold-chain logistics represents an area of growth within pharmaceutical logistics, with a projected CAGR of 5.96%. Its development highlights the importance of logistics capabilities supporting pharmaceutical products that require temperature-controlled transportation and storage.

Cell & gene therapies also represent an important growth area, with a projected CAGR of 6.55%. The segment points to the relevance of specialized logistics services in supporting pharmaceutical products with distinct supply-chain requirements.

The Asia-Pacific region is identified with a CAGR of 5.37%, positioning it among the faster-growing regional markets in the forecast. The market's regional outlook provides an area for examining pharmaceutical logistics activity across the region.

Which Companies Are Leading the Pharmaceutical Logistics Market?

The pharmaceutical logistics market includes companies operating across healthcare logistics, pharmaceutical distribution, temperature-controlled transportation, storage and supply-chain services. The companies profiled in the supplied market information include DHL Group, UPS Healthcare, FedEx Corporation, Kuehne+Nagel, DSV, CEVA Logistics, Cencora, Cryoport Systems, Lineage, Americold Realty Trust, Nichirei Logistics Group, Controlant and TraceLink.

Top Key Companies

DHL Group

UPS Healthcare

FedEx Corporation

Kuehne+Nagel

DSV

CEVA Logistics

Cencora

Cryoport Systems

Lineage

Americold Realty Trust

Nichirei Logistics Group

Controlant

TraceLink

How Is the Pharmaceutical Logistics Market Segmented?

By Service Type

The pharmaceutical logistics market is segmented by Service Type. The supplied market information does not specify the individual service-type categories.

By Mode of Operation

The market is segmented by Mode of Operation. Detailed operating-mode categories were not provided in the supplied information.

By Product Type

The pharmaceutical logistics market covers Product Type segmentation. The supplied information identifies cell & gene therapies as a faster-growing segment, with a CAGR of 6.55%.

By Region

The market is covered across North America, Europe, APAC, South America and MEA. Asia-Pacific is identified with a CAGR of 5.37%.

What Are the Regional Insights for the Pharmaceutical Logistics Market?

The pharmaceutical logistics market report covers North America, Europe, APAC, South America and MEA. Asia-Pacific is identified as a faster-growing regional segment, with a CAGR of 5.37%.

The supplied market information does not provide individual market sizes, market shares or comparative growth rates for all regions. Therefore, a comprehensive quantitative regional comparison cannot be established from the available data.

Industry Insights

Pharmaceutical logistics encompasses services supporting the storage, transportation and distribution of pharmaceutical products across supply chains. The market's segmentation by service type, mode of operation, product type and region provides a framework for evaluating different logistics requirements and geographic markets.

Cold-chain logistics and cell & gene therapies are identified as faster-growing segments, reflecting their importance within the market forecast. Value-added Services and Others also form part of the market segmentation, while Asia-Pacific is identified as a faster-growing region.

Market Concentration and Competitive Landscape

The competitive landscape includes DHL Group, UPS Healthcare, FedEx Corporation, Kuehne+Nagel, DSV, CEVA Logistics, Cencora, Cryoport Systems, Lineage, Americold Realty Trust, Nichirei Logistics Group, Controlant and TraceLink.

These companies are identified as key participants in the supplied market information. Individual market-share figures, company rankings and company-specific revenue estimates for pharmaceutical logistics have not been provided.

Market Dynamics

Market Drivers

The market's growth outlook is assessed across service type, mode of operation, product type and region. Cold-chain logistics and cell & gene therapies are identified as faster-growing segments within the market forecast.

Market Restraints

Specific market restraints are not provided in the supplied market information.

Market Opportunities

Cold-chain logistics, cell & gene therapies and Asia-Pacific are identified as faster-growing segments or regional areas in the supplied market outlook.

Market Challenges

Specific market challenges are not provided in the supplied market information.

Frequently Asked Questions (FAQs)

What is the pharmaceutical logistics market size in 2025?

The pharmaceutical logistics market size is USD 600.07 Billion in 2025.

What will the pharmaceutical logistics market size be in 2035?

The market is projected to reach USD 1,059.54 Billion by 2035.

What is the expected CAGR of the pharmaceutical logistics market?

The market is expected to register a CAGR of 5.85% from 2026 to 2035.

What is the CAGR for cold-chain logistics?

Cold-chain logistics is identified with a CAGR of 5.96%.

What is the CAGR for cell & gene therapies?

Cell & gene therapies are identified with a CAGR of 6.55%.

What is the CAGR for Asia-Pacific?

Asia-Pacific is identified with a CAGR of 5.37%.

Which segments are covered in the pharmaceutical logistics market?

The market scope covers Service Type, Mode of Operation, Product Type and Region.

Which regions are covered in the report?

The report covers North America, Europe, APAC, South America and MEA.

Which companies are profiled in the pharmaceutical logistics market?

The companies profiled include DHL Group, UPS Healthcare, FedEx Corporation, Kuehne+Nagel, DSV, CEVA Logistics, Cencora, Cryoport Systems, Lineage, Americold Realty Trust, Nichirei Logistics Group, Controlant and TraceLink.

What is the forecast period for the pharmaceutical logistics market?

The forecast period is 2026–2035, with historical data covering 2021–2024 and a study period of 2021–2035.

Research Methodology

The pharmaceutical logistics market assessment uses a triangulated approach combining bottom-up vendor revenue aggregation, top-down TAM validation, expert interviews and secondary research. The methodology includes 42 expert interviews and secondary research across 25+ databases.

The assessment incorporates market evaluation across service type, mode of operation, product type and region. Bottom-up vendor revenue aggregation and top-down TAM validation form the components of the triangulated approach, supported by primary and secondary research inputs.

Table of Contents

Introduction 2025

Research Scope

Market Segmentation

Research Methodology

Definitions and Assumptions

Executive Summary 2025

Market Dynamics 2025

Market Drivers

Market Restraints

Market Opportunities

Market Challenges

Key Insights 2025

Key Industry Developments

Porter’s Five Forces Analysis

SWOT Analysis

Technological Developments

Value Chain Analysis

TOC Continued…!

Conclusion

The pharmaceutical logistics market is projected to grow from USD 600.07 Billion in 2025 to USD 1,059.54 Billion by 2035, registering a CAGR of 5.85% from 2026 to 2035. Cold-chain logistics, cell & gene therapies and Asia-Pacific are identified as faster-growing segments or regional areas, with respective CAGRs of 5.96%, 6.55% and 5.37%. The market assessment covers service type, mode of operation, product type and region, with a triangulated research methodology incorporating vendor revenue aggregation, TAM validation, 42 expert interviews and secondary research across 25+ databases.